Brainstorm Cell Therapeutics (BCLI)_個股概要_股票價格_行情走勢圖

0.435
+0.057+15.10%

收盤價 05/01 16:00 (美東)

0.433
-0.002-0.44%

盤後 18:28 (美東)

2969.45萬總市值-1086市盈率TTM

代碼股票名稱

最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業

評論

健谈的克利夫兰

8小時前

$Brainstorm Cell Therapeutics(BCLI.US)$ 好今天晚上會上⬆️⬆️⬆️到9了

已翻譯

Claudine101

04/12 00:27

$Brainstorm Cell Therapeutics(BCLI.US)$ why is it going down with all the good news 🤔

Trytosaveabit

04/11 18:01

Nice!

$Brainstorm Cell Therapeutics(BCLI.US)$ Brainstorm Cell Therapeutics Regains Compliance With Nasdaq Minimum Market Value Rule

Double_Bottom

04/10 22:43

$Brainstorm Cell Therapeutics(BCLI.US)$ need more volume on good news.....waiting for liftoff

Trytosaveabit

04/10 18:04

$Brainstorm Cell Therapeutics(BCLI.US)$ BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS NurOwn treatment resulted in a positive impact on important CSF biomarkers relevant to ALS compared to placebo. Significant changes in multiple ALS disease pathways support NurOwn's mechanism of action and complement clinical effects observed in ALS.

BCLI Brainstorm Cell Therapeutics

資金分布

資金流向

新聞

評論

Nice!

Update

分析

分析師評級

目標價預測